EligibleTrials

Clinical trials recruiting for Ras (KRAS or NRAS) Gene Mutation

3
Recruiting trials
10
US states with sites
3
Countries
33%
Accept healthy volunteers

Phase breakdown

Phase 1 1Phase 2 1Not applicable 1

Drugs and treatments being studied

InterventionTrials
Leflunomide1
NST-6281
The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab1

Where trials are recruiting (top US states)

StateRecruiting trials
California1
Colorado1
Connecticut1
Florida1
New York1
Pennsylvania1
Tennessee1
Texas1
Utah1
Virginia1

Top cities

Austin, Texas 1Buffalo, New York 1Dallas, Texas 1Denver, Colorado 1Fairfax, Virginia 1Houston, Texas 1Nashville, Tennessee 1New Haven, Connecticut 1New York, New York 1Pittsburgh, Pennsylvania 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Ras (KRAS or NRAS) Gene Mutation often also study these conditions. Each links to its own recruiting-trial list.

Melanoma 487Colorectal cancer 1359Solid Tumor, Adult 38Refractory Cancer 6RAS Mutation 6Pancreatic cancer 870Pancreas Cancer 86Oncology 8Non-small cell lung cancer 507Lung cancer 2180

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Ras (KRAS or NRAS) Gene Mutation trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.